4-Brom-2,5-dimethoxyphenylethylamine (2C-B) cas: 66142-81-2

CAS NO: 66142-81-2
Chemical Name: (+/-) 1-(4-BROMO-2 5-DIMETHOXYPHENYL)-2&
Molecular Formula: C10H14BrNO2
Formula Weight: 260.13
CAS No.: 66142-81-2
Description Review
Description

2-Brom-2,5-dimethoxyphenylethylamine, or 2C-B, is a psychoactive substance that has been used in a number of therapeutic and psychological studies. 



(2C-B) is the chemical name for 4-Brom-2,5-dimethoxyphenylethylamine.

In order to learn more about 2C-B,

2C-B effects, 4-Brom-2,5-dimethoxyphenylethylamine research, 2C-B safety profile, legal status of 2C-B, 2C-B psychotherapy application.

Comparable Competitive Products

Other 2C-B-like substances

4-Brom-2,5-dimethoxyphenylethylamine properties,

research on 4-Brom-2,5-dimethoxyphenylethylamine,

effects of 4-Brom-2,5-dimethoxyphenylethylamine,

4-Brom-2,5-dimethoxyphenylethylamine toxicity,

synthesis of 4-Brom-2,5-dimethoxyphenylethylamine.
4-Brom-2,5-dimethoxyphenylethylamine (2C-B) cas: 66142-81-2


MDMA, also known as Ecstasy

Lysergic acid diethylamide, or LSD

2C-E: An additional 2C family member with psychedelic characteristics

Advantages for Health
While not licensed for medical use, 2C-B has been studied for its possible therapeutic benefits, notably in improving psychotherapy by potentially lowering inhibition and boosting insight.

Possible Repercussions
2C-B is famous for its trippy effects, which can include seeing and sensing colors and sounds more clearly, feeling happy, and seeing time differently. Researchers in the fields of psychology and medicine are interested in it because of these impacts.

Product Operation
Mood, cognition, and perception are all altered as a result of the role that 2C-B plays as a serotonin receptor agonist. Although similar to other serotonergic psychedelics, its mechanism is different.

Security and Adverse Reactions

2C-B's safety profile requires careful assessment, just like that of any psychoactive drug. Nausea, headaches, and elevated heart rate are some of the side effects, with more severe psychological responses likely in sensitive people.

Information about Dosing
With regard to the intended degree of effect intensity, the typical dosage range for 2C-B is from 5 to 30 mg. It's important to be careful when taking because the compound's effects aren't always clear.

Restrictions

2C-B should not be used by anybody who has a history of cardiovascular disease, mental illness, or who is taking any medicine that interacts with serotonin systems, including SSRIs.

Within the confines of the law, 2C-B continues to be a chemical that provides a great amount of interest for both scientific investigation and personal exploration. Psychotherapy may use its psychedelic characteristics, but safety steps must be taken to reduce its hazards.

1. What Are the Main Applications of 2C-B?
2C-B is largely employed for its psychedelic characteristics in settings aimed at exploring consciousness, as well as for personal discovery in legal circumstances.

2. Is 2C-B secure to use for recreational purposes?
Safety can change a lot depending on the person, the dose, and the situation. There are hazards associated with recreational usage, especially when done so unsupervised or with other drugs.

3. Is the use of 2C-B in treatment possible?
To improve emotional openness and awareness, 2C-B is being considered for psychotherapy. This field is still being studied, however, and it is not yet commonly acknowledged or used.

4. What should be done if someone takes too much 2C-B?
It is imperative to promptly seek medical attention in situations involving an overdose. To safely handle any side effects, it's important to get supportive care in a medical setting.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code